A detailed history of Pictet Asset Management Holding Sa transactions in Novavax Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 16,291 shares of NVAX stock, worth $138,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,291
Previous 16,291 -0.0%
Holding current value
$138,636
Previous $206,000 0.49%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.89 - $20.97 $23,219 - $125,169
5,969 Added 57.83%
16,291 $206,000
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $70,292 - $100,536
10,322 New
10,322 $74,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.